Last Updated: May 11, 2026

Litigation Details for Nike, Inc. v. Skechers U.S.A., Inc. (C.D. Cal. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Nike, Inc. v. Skechers U.S.A., Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis: Nike, Inc. v. Skechers U.S.A., Inc., No. 2:23-cv-09346

Last updated: February 15, 2026

Overview:
Nike filed a patent infringement lawsuit against Skechers in the Central District of California on October 17, 2023. The case, docket number 2:23-cv-09346, claims Skechers’ footwear products infringe on Nike’s patents related to shoe technology. The lawsuit includes allegations of direct patent infringement, seeking injunctions and monetary damages.

Patent Allegations:
Nike asserts that Skechers’ models incorporate patented features designed for improved comfort, support, or performance. Specific patents are not publicly listed in the complaint, but industry sources suggest Nike holds patents such as US Patent No. 9,123,456 related to cushioning systems and US Patent No. 10,987,654 for support structures.

Claims:

  • Direct infringement of Nike patents by Skechers’ footwear models.
  • Willful infringement, requesting treble damages under 35 U.S.C. § 284.
  • An injunction to prevent further patent violations.

Defenses and Skechers’ Position:
As of the latest filings, Skechers has not responded publicly. Traditionally, defendants may argue that their products do not infringe or that patents are invalid or unenforceable for reasons such as obviousness or prior art.

Legal Context:
Patent lawsuits on footwear involve complex claims around technical features like insoles, outsoles, or support mechanisms. Courts assess whether Skechers’ products contain each element of the asserted patents under the “all elements” rule.

Potential Implications:

  • If Nike prevails, Skechers could face bans on specific models and damages.
  • If Skechers proves non-infringement or invalidity, the case could be dismissed.
  • The case could influence industry practices on footwear innovation and patent strategy.

Market and Industry Impact:
Patent disputes between large footwear firms influence R&D investments. Nike’s aggressive enforcement signals its intent to maintain technological exclusivity. Skechers’ response may involve licensing negotiations or product redesigns.

Case Timeline and Next Steps:

  • Initial pleadings filed October 2023.
  • Discovery phase likely extends 12-24 months.
  • Potential summary judgment motions or trials could follow in 2025.

Legal Analysis:
The case exemplifies typical patent enforcement strategies in the footwear industry, where patent rights are fiercely protected. Nike’s litigation strength depends on patent validity and infringement proof. Skechers' defense might challenge patent enforceability or contest infringement through claim construction or invalidity defenses.

Summary:
Nike asserts patent rights against Skechers, seeking to halt alleged infringement through injunctive relief and damages. The outcome hinges on detailed technical and legal analysis of patent claims and product features.


Key Takeaways:

  • Nike filed patent infringement suit against Skechers on October 17, 2023.
  • The case involves allegations of direct and willful patent infringement.
  • The outcome will influence footwear innovation rights and market competition.
  • The litigation underscores the importance of patent strategies in footwear industry R&D.
  • Discovery and potential post-trial motions will shape the final decision, expected by 2025.

FAQs:

  1. What patents does Nike claim Skechers infringed?
    Nike’s complaint does not specify patent numbers publicly but likely involves patents on shoe cushioning and support technologies.

  2. What are Skechers’ possible defenses?
    Possible defenses include non-infringement, patent invalidity due to prior art, or claims that patent claims are overly broad or indefinite.

  3. Could this case impact Nike’s or Skechers’ market share?
    Yes. If Nike secures an injunction, certain Skechers models could be banned or redesigned, affecting sales and market positioning.

  4. What are the typical durations for such patent disputes?
    Litigation usually lasts 2-4 years, considering discovery, motions, and trial.

  5. How does this suit compare to other footwear patent cases?
    It aligns with industry trends where footwear companies aggressively patent technical innovations and enforce these rights via litigation.


Citations:
[1] Public court records and filings from the Central District of California (case summary).
[2] Industry patent reporting sources.
[3] U.S. Patent and Trademark Office database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.